Dr Dani Gordon on CBD Oil

Dr Dani Gordon, co-founder of the Primary Care Cannabis Network, recently featured in the Business Insider, to provide an insight into CBD Oil, the costs surrounding the product and how it can support our well-being.


The Business Insider recently labelled the world of CBD Oil as a ‘minefield for newcomers’ - more often than not, people go out to purchase products they know little to nothing about. Wanting to find out more about the new phenomenon, so many people are taking an interest in, The Business Insider interviewed Dr Dani to ask ‘why are CBD oils justified for being so expensive?’


Dr Dani explains: “CBD stands for Cannabidiol - the chemical name for one of the chemicals in the cannabis plant. Made from low-THC - consumers can buy it without a prescription, and use it for a variety of purposes such as inflammation, anxiety, stress and general wellness.”


As customers can purchase CBD products without a prescription, manufacturers must be conscious to not make any medical claims. So why, then, does that mean there is so much difference in price? The Business Insider has reported sales have tripled in the last 3-years.


More of a supplement than a treatment, the younger generation who are indeed more aware of health and mental well-being, seem to be flocking to the shelves.


How can we assess the value of CBD oil? - asks the Business Insider

“Manufacturers take the cannabis plant, process it and come up with an extract which doesn’t only have traces of CBD, but also terpenoids - what you get is actually greater than the sum of its parts,” continues Dr Dani.


CBD isolate - a pure CBD devoid of other chemicals within the plant - features in more expensive products, but is considered to be less effective. That’s because the cost of making CBD isolate is lower than making a full or broad-spectrum CBD product.


Dr Dani says: “Sometimes you have to dig more into the nitty-gritty of the ingredients. Labelling criteria is becoming stricter, so more consumers can understand what is a CBD isolate product, and what is not.”


Dr Dani explains how consumers can look out for the number of milligrams (mg) in the bottle and then in the dosage to help you find out whether or not the product is worth the price.


Recent studies

The Centre for Medicinal Cannabis recently found that 62% of CBD products tested in the UK didn’t contain the same CBD amount as printed on the label. Interestingly, 62% of CBD users reported they use CBD oil to treat a medical condition.


As more studies are reported and more research is carried out into medical cannabis and cannabis-based products such as CBD oil; the public and medicinal world will gain a greater understanding into the effects, treatments and value of cannabis as a medicine.


“Always look for the Certificate of Analysis - this will tell you your new CBD product isn’t contaminated, doesn’t contain anything which could harm you and doesn’t have THC levels above the allowed limit,” adds Dr Dani.


The Primary Care Cannabis Network aims to expand the knowledge of cannabis-based medical treatments and is focussed on academic research, education, key-papers and open discussions. We focus specifically on the needs of GPs and as more GPs across the UK reach out to the Primary Care Cannabis Network for more information on Medical Cannabis, a bigger community is forming which will enable GPs to confidently work together and with specialists to understand the various regulatory pathways that exist within the UK.


Moving forwards into 2020, the PCCN will host a series of events on Medical Cannabis and will also be key-note speakers at other seminars within industry. For more information on these events or to be kept up-to-date with the latest news and member meeting, subscribe to our Journal Club today.


Watch Dr Dani Gordon on the Business Insider here.

  • Twitter
  • LinkedIn

Privacy Policy |  © 2020 Copyright - Medical Cannabis Clinicians’ Society


DISCLAIMER:  All views are those of The Primary Care Cannabis Network. Information on this site is written for the purpose of general education. Information is not specific to any specific medical case and should not be taken to provide a diagnosis or treatment. This material should not be reproduced without the specific permission of the The Primary Care Cannabis Network. The opinions expressed here are of our society and do not necessarily represent the views of any other institutions of which members are affiliated with. The Primary Care Cannabis Network takes no responsibility for any actions taken by individuals in response to the information given here.